63 related articles for article (PubMed ID: 33611864)
1. Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer.
Mori Y; Okimoto Y; Sakai H; Kanda Y; Ohata H; Shiokawa D; Suzuki M; Yoshida H; Ueda H; Sekizuka T; Tamura R; Yamawaki K; Ishiguro T; Mateos RN; Shiraishi Y; Yatabe Y; Hamada A; Yoshihara K; Enomoto T; Okamoto K
Cell Rep Med; 2024 Apr; ():101532. PubMed ID: 38670097
[TBL] [Abstract][Full Text] [Related]
2. Cancer progression: is inhibin alpha from Venus or Mars?
Ball EM; Mellor SL; Risbridger GP
Cytokine Growth Factor Rev; 2004 Oct; 15(5):291-6. PubMed ID: 15450247
[TBL] [Abstract][Full Text] [Related]
3. Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction.
Mandai M; Amano Y; Yamaguchi K; Matsumura N; Baba T; Konishi I
Oncotarget; 2015 Oct; 6(31):30704-14. PubMed ID: 26375553
[TBL] [Abstract][Full Text] [Related]
4. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.
Kusumoto S; Kurashige M; Ohshima K; Tahara S; Matsui T; Nojima S; Hattori S; Morii E
Cancer Med; 2021 Mar; 10(5):1485-1500. PubMed ID: 33611864
[TBL] [Abstract][Full Text] [Related]
5. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
[TBL] [Abstract][Full Text] [Related]
6. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
Oncogene; 2016 Jan; 35(4):468-78. PubMed ID: 25893298
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma.
Wang H; Tan M; Zhang S; Li X; Gao J; Zhang D; Hao Y; Gao S; Liu J; Lin B
Int J Mol Sci; 2015 Feb; 16(2):3391-404. PubMed ID: 25658794
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas.
Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama N; Otsuki Y; Nakayama S; Miyazaki K
Br J Cancer; 2012 Jul; 107(2):300-7. PubMed ID: 22653145
[TBL] [Abstract][Full Text] [Related]
9. Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.
Hsu IL; Chou CY; Wu YY; Wu JE; Liang CH; Tsai YT; Ke JY; Chen YL; Hsu KF; Hong TM
Oncotarget; 2016 Sep; 7(39):62925-62938. PubMed ID: 26910837
[TBL] [Abstract][Full Text] [Related]
10. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
Hen O; Barkan D
Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
[TBL] [Abstract][Full Text] [Related]
11. Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis.
Singh P; Jenkins LM; Horst B; Alers V; Pradhan S; Kaur P; Srivastava T; Hempel N; Győrffy B; Broude EV; Lee NY; Mythreye K
Cancer Res; 2018 Jun; 78(11):2978-2989. PubMed ID: 29535220
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles.
Treps L; Perret R; Edmond S; Ricard D; Gavard J
J Extracell Vesicles; 2017; 6(1):1359479. PubMed ID: 28815003
[TBL] [Abstract][Full Text] [Related]
13. Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling.
Yeh YW; Cheng CC; Yang ST; Tseng CF; Chang TY; Tsai SY; Fu E; Chiang CP; Liao LC; Tsai PW; Yu YL; Su JL
Oncotarget; 2017 Jan; 8(3):5603-5618. PubMed ID: 27901498
[TBL] [Abstract][Full Text] [Related]
14. iPSC-derived cancer stem cells provide a model of tumor vasculature.
Prieto-Vila M; Yan T; Calle AS; Nair N; Hurley L; Kasai T; Kakuta H; Masuda J; Murakami H; Mizutani A; Seno M
Am J Cancer Res; 2016; 6(9):1906-1921. PubMed ID: 27725898
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
